Department of Radiation Oncology, Mayo Clinic College of Medicine and Science, 200 First St SW, Rochester, MN, 55905, USA.
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
J Neurooncol. 2020 May;148(1):89-95. doi: 10.1007/s11060-020-03492-x. Epub 2020 Apr 17.
Stereotactic radiosurgery (SRS) is commonly performed after surgical resection of brain metastases to reduce the chance of local tumor recurrence while maintaining cognitive function. Target delineation in these cases is typically based off T1-weighted post-gadolinium MRI (T1Gd). In this study, we report outcomes for patients having postoperative SRS in which the planning target volume (PTV) was based on T2-weighted MRI (T2W).
Sixty-two consecutive patients having single-fraction SRS after brain metastases resection were retrospectively reviewed. Excluded were patients with prior whole brain radiation therapy, multiple resection cavities, and small cell pathologies.
The median time from surgery to SRS was 11 days; 26 patients (42%) had SRS ≤ 7 days. The median PTV was 8.0 cm; the median margin dose was 18 Gy. The crude rates of local tumor control (LC), leptomeningeal disease (LMD), distant brain recurrence (DBR), and radiation necrosis (RN) were 85%, 19%, 37%, and 2%, respectively. The 1-year LC, LMD, DBR, and RN rates were 88%, 25%, 36%, and 0%, respectively. No tumor or dosimetric factor was associated with LC. Sub-total tumor resection was a risk factor for LMD (HR 5.11, P = 0.003), whereas patients with multiple brain metastases had a greater risk of DBR (HR 2.88, P = 0.01). The median PTV was smaller compared to the median PTV based off the consensus guidelines utilizing T1Gd MRI (8.0 cm vs. 9.1 cm, P = 0.004).
T2W MRI provided accurate resection cavity delineation even in the early postoperative period and was associated with decreased PTV compared to T1Gd MRI in the majority of cases.
立体定向放射外科(SRS)通常在脑转移瘤手术后进行,以降低局部肿瘤复发的机会,同时保持认知功能。在这些情况下,靶区勾画通常基于 T1 加权钆后 MRI(T1Gd)。本研究报告了在术后 SRS 中使用 T2 加权 MRI(T2W)勾画计划靶区(PTV)的患者的结果。
回顾性分析 62 例脑转移瘤切除术后行单次分割 SRS 的连续患者。排除标准包括:既往全脑放疗、多个切除腔和小细胞病理。
从手术到 SRS 的中位时间为 11 天;26 例(42%)患者 SRS 时间≤7 天。PTV 中位数为 8.0cm;中位边缘剂量为 18Gy。局部肿瘤控制(LC)、软脑膜疾病(LMD)、远处脑复发(DBR)和放射性坏死(RN)的粗率分别为 85%、19%、37%和 2%。1 年 LC、LMD、DBR 和 RN 率分别为 88%、25%、36%和 0%。肿瘤或剂量学因素均与 LC 无关。肿瘤次全切除是 LMD 的危险因素(HR 5.11,P=0.003),而多发脑转移是 DBR 的危险因素(HR 2.88,P=0.01)。与基于 T1Gd MRI 的共识指南相比,大多数情况下 T2W MRI 勾画的 PTV 更小(8.0cm 比 9.1cm,P=0.004)。
T2W MRI 即使在术后早期也能准确勾画切除腔,与 T1Gd MRI 相比,大多数情况下 PTV 更小。